CAPTRUST Financial Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-5,327
| Closed | -$216K | – | 2733 |
|
|
2025
Q2 | $216K | Hold |
5,327
| – | – | ﹤0.01% | 2252 |
|
|
2025
Q1 | $233K | Sell |
5,327
-500
| -9% | -$22.1K | ﹤0.01% | 2093 |
|
|
2024
Q4 | $251K | Buy |
5,827
+500
| +9% | +$22.7K | ﹤0.01% | 2012 |
|
|
2024
Q3 | $236K | Sell |
5,327
-10
| -0.2% | -$428 | ﹤0.01% | 2036 |
|
|
2024
Q2 | $212K | Buy |
5,337
+63
| +1% | +$2.55K | ﹤0.01% | 2007 |
|
|
2024
Q1 | $227K | Hold |
5,274
| – | – | ﹤0.01% | 1934 |
|
|
2023
Q4 | $220K | Sell |
5,274
-2
| -0% | -$76 | ﹤0.01% | 2333 |
|
|
2023
Q3 | $210K | Buy |
5,276
+300
| +6% | +$12.7K | ﹤0.01% | 2255 |
|
|
2023
Q2 | $204K | Buy |
+4,976
| New | +$205K | ﹤0.01% | 2253 |
|
|
2022
Q3 | – | Sell |
-1,463
| Closed | -$61K | – | 4105 |
|
|
2022
Q2 | $61K | Buy |
1,463
+75
| +5% | +$3.15K | ﹤0.01% | 2593 |
|
|
2022
Q1 | $63K | Buy |
1,388
+261
| +23% | +$11.5K | ﹤0.01% | 2622 |
|
|
2021
Q4 | $52K | Buy |
1,127
+1,053
| +1,423% | +$49.9K | ﹤0.01% | 2640 |
|
|
2021
Q3 | $4K | Hold |
74
| – | – | ﹤0.01% | 4060 |
|
|
2021
Q2 | $4K | Hold |
74
| – | – | ﹤0.01% | 3968 |
|
|
2021
Q1 | $4K | Hold |
74
| – | – | ﹤0.01% | 3830 |
|
|
2020
Q4 | $4K | Buy |
+74
| New | +$3.54K | ﹤0.01% | 2946 |
|
|
2020
Q3 | – | Sell |
-74
| Closed | -$3K | – | 3264 |
|
|
2020
Q2 | $3K | Buy |
+74
| New | +$3.06K | ﹤0.01% | 2531 |
|
|
2018
Q4 | – | Sell |
-200
| Closed | -$10K | – | 1690 |
|
|
2018
Q3 | $10K | Hold |
200
| – | – | ﹤0.01% | 1237 |
|
|
2018
Q2 | $9K | Hold |
200
| – | – | ﹤0.01% | 1213 |
|
|
2018
Q1 | $8K | Sell |
200
-140
| -41% | -$6.1K | ﹤0.01% | 1093 |
|
|
2017
Q4 | $15K | Buy |
340
+140
| +70% | +$5.95K | ﹤0.01% | 887 |
|
|
2017
Q3 | $8K | Buy |
+200
| New | +$8.48K | ﹤0.01% | 453 |
|
Other funds holding XPH
FCBT
